Screening group B streptococcus in perinatal infection：detection methods and clinical value
10.3760/cma.j.issn.1009-9158.2016.06.004
- VernacularTitle:B 族链球菌检测在围产期孕妇感染诊断中的意义
- Author:
Ying ZHANG
;
Chunmei YING
- Publication Type:Journal Article
- Keywords:
Streptococcus agalactiae;
Streptococcal infections;
Peripartum period;
Microbiological techniques;
Immunoassay;
Clinical laboratory techniques
- From:
Chinese Journal of Laboratory Medicine
2016;39(6):410-412
- CountryChina
- Language:Chinese
-
Abstract:
Group B Streptococcus ( GBS) is a conditional pathogenic bacteria related to late-term abortion, premature delivery, premature rupture of membranes, perinatal infection, neonatal sepsis and other diseases.Prevention and treatment guidelines by the US Centers for Disease Control and Prevention ( CDC) suggest that all the pregnant women at 35-37 gestational weeks should screen for GBS .The detection methods for GBS include microbiology , immunology, molecular biology, etc.The appropriate method should be chosen depending on circumstances .Penicillin is recommended for the preventive treatment of GBS , and the treatment for the insensitive should base on the antibiotic susceptibility results .No vaccine against GBS is currently available for clinical use .
